Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Equivalence of fluticasone propionate via Novolizer vs Diskus in moderate to severe asthma
2005-001730-32Phase 3Completed
- Sponsor
- Viatris
- Start
- Aug 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluticasone propionate in asthma (2 arms), sponsored by Viatris. Primary endpoint: Morning pre-dose FEV1. Started Aug 2005; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on 2005-001730-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001730-32.